Omega Healthcare Investors (OHI) Stock Analysis & Forecast

Nov 13 close

$47.05+0.02 (0.0%)

Gekko Brief

AI summaryNov 9 close

Omega Healthcare Investors moved this week on third-quarter results and a raised outlook. The company reported funds from operations of $262.1 million, or 82 cents per share, ahead of the average analyst estimate of 81 cents, and raised its full-year 2026 adjusted funds from operations guidance to a range of $3.28 to $3.30 per share. The quarter included $181 million in transactions covering five US senior living communities and six UK care homes, along with the transition of Florida skilled nursing facilities to a new operator at higher rent. Occupancy reached 82.7%, EBITDAR coverage improved to 1.67x, and leverage fell to 3.1x. Separate coverage noted an average price target of $49.93 from a group of analysts holding an average "Hold" rating, while filings showed mixed fund activity in the stock.

OHI closed at $48.83, up 1.3%, with price sitting above both the 50-day average of $46.34 and the 200-day average of $46.73. The GekkoIndex reading stands at 47.8, placing the stock in the Neutral zone after a five-point change of -6.2. Price remains 27.1% below Gekko Fair Value of $67.

The next earnings date is 3 February 2027, 85 days out, beyond a typical 20-trading-day holding period. No insider, Congress, or unusual options activity appears in the recent windows. Seasonality over five years shows an average 20-trading-day return of -1.6% from this point, with gains in 1 of those years, a factor worth noting alongside the current consensus target of $51.37.

Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.

Omega Healthcare Investors price vs fair value

▲$64.44$47.05Nov ’25May ’26Nov ’26
Close $47.05200-day averageGekko Fair Value $64.44

Omega Healthcare Investors quick facts

Market cap
$14.32B
P/E ratio
19
Forward P/E
10.1
EPS, TTM
$2.47
Revenue, TTM
$1.26B
Profit margin
60.5%
Dividend yield
5.61%
Beta
0.55
Volume
2.57M avg 2.19M
1-year return
+7.7%
Typical daily move
±2.3%
Typical 20-day move
±4%
50-day average
$46.42
200-day average
$46.81
Next earnings
Feb 3
Shares outstanding
304.3M
52-week range
$42.18$52.39

Omega Healthcare Investors swing-trade checklist

Omega Healthcare Investors scores 2 supportive, 2 mixed and 1 headwind across the 5 checklist items with data.

Six things swing traders check before a 20-day hold, read from the latest data.

2 supportive2 mixed1 headwind

  • Trendmixed

    Averages disagree

    Close $47.05 sits between the 50-day ($46.42) and 200-day ($46.81) averages, or the averages disagree.

    See the chart
  • GekkoIndexmixed

    56.3, Neutral

    Reading 56.3 is in the Neutral zone.

    See the GekkoIndex
  • Fair valuesupportive

    27.0% below

    Price is 27% below Gekko Fair Value (more than 5% below).

    See fair value
  • Smart moneyno data

    No data

    No insider, Congress or unusual options activity in the window.

    See smart money
  • Earnings risksupportive

    Reports in 80 days

    Next report Feb 3, 2027, 80 days away — outside a typical 20-trading-day hold.

    See earnings
  • Seasonalityheadwind

    −2.5% on average

    From this point in the calendar, the next 20 trading days averaged −2.5% over 5 years, rising in 1 of them.

    See seasonality

A description of current data, not a recommendation. How this page works

Omega Healthcare Investors stock chart and price history

Omega Healthcare Investors closed at $47.05 on Nov 13, 2026, +7.7% over the past year, inside a 52-week range of $42.18 to $52.39.

Close50-day average200-day averageVolume
Omega Healthcare Investors share price, past year, with 50-day and 200-day moving averages and volume$40$45$50DecJan 2026FebMarAprMayJunJulAugSepOctNov47.05

Use the left and right arrow keys to read daily values.

Performance Breakdown

1 month
+3.3%
3 months
+1.0%
6 months
−0.6%
1 year
+7.7%
The full OHI chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open OHI in Gekko

Follow Omega Healthcare Investors through every session

Put OHI on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.

Track OHI in GekkoFree for 7 days. No credit card required.

About Omega Healthcare Investors

Omega Healthcare Investors operates as a real estate investment trust that puts its money into properties used for skilled nursing and assisted living care. Rather than running these facilities itself, it owns the buildings and works with a range of healthcare operators who take on the day-to-day management of the properties.

Most of its arrangements with these operators are structured as triple-net leases, meaning the tenants typically cover costs like taxes, insurance and maintenance on the properties they occupy. Its holdings stretch across every region of the United States, with additional properties located in the United Kingdom.

Omega Healthcare Investors trades under the ticker OHI.

Sector
Finance
Website
omegahealthcare.com

Omega Healthcare Investors GekkoIndex: the smart money zone

Omega Healthcare Investors’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 56.3, in the Neutral zone, up 6.8 points over five sessions.

010056.3Neutral

Up 6.8 points over five sessions.

Reading for Nov 13, 2026

What followed past readings in each zone

ZoneReadings5 days10 days20 days50 days
Buying11+1.7%+1.5%+5.6%+2.2%
Accumulation187+0.7%+1.6%+2.4%+3.3%
Neutral (current zone)433+0.2%+0.3%+0.8%+3.7%
Distribution24−0.1%+0.8%+2.1%+4.5%
Selling0Not available

Average OHI share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.

Neutral zone: No clear directional signal. About the five zones →

See every daily GekkoIndex reading plotted over the OHI price, zone by zone.Track OHI in Gekko

Is Omega Healthcare Investors stock overvalued? Gekko Fair Value

Omega Healthcare Investors trades 27.0% below Gekko Fair Value of $64.44, so the shares are undervalued on Gekko’s estimate.

Gekko’s own estimate of what Omega Healthcare Investors shares are worth, recalculated every trading day.

$64.44

Gekko Fair Value, Nov 14, 2026

27.0% Undervalued

At the end of Aug 2026 the price was 33.8% below the estimate.

Gekko Fair ValueShare price, month end
$64$47Aug 2026SepOctNov 2026

How Gekko Fair Value works →

Gekko Fair Value on every chart, with the gap to price updating daily.Open OHI in Gekko

Omega Healthcare Investors insider and Congress trading

No open-market insider purchases were filed for Omega Healthcare Investors, and no Congress trades were disclosed, in the last 90 days.

Plus buybacks, unusual options and fund positions, each dated to when it became public.

Insider buying last 90 days

No open-market insider purchases were filed for OHI in the last 90 days.

From Form 4 filings, dated to when each was filed.

Every OHI insider filing, plotted on the chart in Gekko.Open OHI in Gekko

Congress trades last 90 days

No trades in OHI were disclosed by members of Congress in the last 90 days.

From congressional disclosures, which report amounts as ranges.

Congress disclosures for OHI, plotted on the chart in Gekko.Open OHI in Gekko

Buybacks

Omega Healthcare Investors has been buying back its own shares.

Bought back, quarter ended Sep 30, 2026
$5.37M
As a share of market cap
0.04%

From company filings.

Omega Healthcare Investors earnings: next date and track record

Omega Healthcare Investors reports on Feb 3, 2027 (80 days away), and beat the EPS estimate in 6 of its last 8 reports.

6 of 8reports beat the EPS estimate
±3.1%average move across the report
5 of 8reports followed by a gain

Share-price move across each report

+1.2%Feb ’25−5.2%May ’25+2.9%Jul ’25−0.3%Oct ’25+6.3%Oct ’25+6.1%Feb ’26+0.1%Apr ’26−2.4%Jul ’26

Last earnings call, Jul 29, 2026 AI summary

What they said
Omega Healthcare Investors reported Q2 2026 results with year-over-year revenue and AFFO growth, driven by new investments, annual escalators, and active portfolio management. Management highlighted a strong balance sheet, significant liquidity from asset sales and loan repayments, and improved operator coverage across the triple-net and SHOP portfolios. The company completed strategic dispositions (notably 18 CommuniCare assets) and proactively transitioned underperforming assets to higher-credit operators (Saber, HHC), which management expects to improve credit and yield future earnings accretion once proceeds are redeployed. Management emphasized a robust pipeline across skilled nursing, senior housing, and U.K. care homes, forecasting increased transaction volume later in 2026 and into 2027. They also noted operational improvements, hiring to expand data/AI, and an anticipated Genesis bankruptcy closing by year-end that will satisfy related loans. Leadership transitions were announced (Taylor Pickett and Bob Stephenson retiring) and management expressed confidence in the next executive team.
Guidance
- Expectation of meaningful increase in transaction dollar volume late 2026 into 2027 based on pending deals forecasted to close. - Anticipated Genesis bankruptcy closing by year-end with buyer assuming master lease and satisfaction of term and DIP loans. - Management indicated Q3 earnings headwind from $563M in asset sales (and some sales late in the quarter impacting Q3). - Mid-single-digit organic FAD growth target over time (management quantified about 6-7% annualized FAD growth as achievable). - No specific numerical quarterly or annual revenue/earnings guidance provided beyond these directional statements.
Risks flagged
- Ongoing Genesis bankruptcy and related credit exposure until closing. - Short-term headwind to sequential earnings/AFFO due to large asset dispositions and loan repayments. - Regulatory risk: increased focus by HHS/CMS on fraud and abuse could create indirect impacts or state budget constraints. - Potential state rate-setting changes in certain markets (a few negative outcomes noted) though not expected to materially impact coverage. - Operator performance variability (need to manage underperforming operators, watch-list risk), though coverage has improved.
ReportedEPSSurpriseRevenueSurpriseMove
Jul 29, 2026$0.83
est $0.77
+7.8%$262.7M
est $267.0M
−1.6%−2.4%
Apr 28, 2026$0.48
est $0.49
−2.0%$266.9M
est $264.1M
+1.1%+0.1%
Feb 4, 2026$0.55
est $0.49
+12.2%——+6.1%
Oct 30, 2025$0.79
est $0.77
+2.6%$311.6M
est $287.2M
+8.5%+6.3%
Oct 29, 2025$0.59
est $0.46
+28.0%$311.6M
est $287.2M
+8.5%−0.3%
Jul 31, 2025$0.77
est $0.75
+2.7%$282.5M
est $247.9M
+14.0%+2.9%
May 1, 2025$0.75
est $0.75
0.0%$276.8M
est $236.7M
+16.9%−5.2%
Feb 5, 2025$0.74
est $0.41
+80.5%$279.3M
est $226.2M
+23.5%+1.2%

“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.

Omega Healthcare Investors stock forecast and analyst price targets

Analysts’ average 12-month price target for Omega Healthcare Investors is $51.68, +9.8% from the last close, from 8 firms rating the stock in the last 90 days.

$51.68consensus 12-month target, +9.8% from the last close
Low $46High $56
Buy3
Hold3
Sell2

Each firm’s latest rating in the last 90 days: 8 firms.

Latest analyst actions

DateFirmRatingTargetvs price
Nov 11UBSBuy, reiterated$56+19.0%
Nov 9Bank of America SecuritiesSell, reiterated$49+4.1%
Nov 4ScotiabankHold, maintained$50+6.3%
Nov 3Wells FargoHold, maintained$46−2.2%
Oct 22Citizens JMPBuy, upgraded$52+10.5%
+0.8%average 20-day move after past Neutral readings
−2.5%average move over the next 20 trading days in the last 5 years
±2.3%typical daily move, from the 14-day average range

Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.

Omega Healthcare Investors seasonality: the next 20 trading days

Over the next 20 trading days from Nov 14, Omega Healthcare Investors averaged −2.5% across the last 5 years, rising in 1 of them.

Next 20 trading days, by year

−2.3%2021−7.5%2022−1.1%2023−1.3%2024+1.3%2025

Average move and hit rate

WindowAverageYears higher
Next 5 trading days+0.3%3 of 5
Next 10 trading days−0.6%2 of 5
Next 15 trading days−1.5%1 of 5
Next 20 trading days−2.5%1 of 5
Next 30 trading days−3.2%2 of 5

For scale, OHI’s typical 20-trading-day move in either direction is about 4%.

Omega Healthcare Investors market cap and key statistics

Omega Healthcare Investors’s market cap is $14.32B, with a P/E ratio of 19 and revenue of $1.26B over the last twelve months.

Valuation

Market cap
$14.32B
P/E ratio
19
Forward P/E
10.1
EPS, TTM
$2.47
Gekko Fair Value
$64.44

Trading

Volume
2.57M
Avg volume, 20 days
2.19M
52-week high
$52.39
52-week low
$42.18
Shares outstanding
304.3M

Financials

Revenue, TTM
$1.26B
Profit margin
60.5%
Return on equity
14.5%
Quarterly earnings growth, YoY
−55.4%

Risk and income

Beta
0.55
Typical daily move
±2.3%
Typical 20-day move
±4%
Dividend yield
5.61%

Omega Healthcare Investors stock news this week

Coverage of Omega Healthcare Investors this week reads positive: 3 positive, 2 neutral and 0 negative headlines.

News sentiment positive

More stocks

In the Buying zone today

Reporting earnings this week

Popular on Gekko

More stocks in Finance

Omega Healthcare Investors stock FAQ

What is Omega Healthcare Investors’s market cap?

Omega Healthcare Investors’s market cap is $14.32B at the Nov 13, 2026 close of $47.05, with 304.3M shares outstanding. The shares trade on a P/E ratio of 19.

What is the Omega Healthcare Investors stock forecast?

The consensus analyst 12-month price target for Omega Healthcare Investors is $51.68, +9.8% from the last close. Of the 8 firms that rated the stock in the last 90 days, 3 rate it a buy, 3 a hold and 2 a sell. Gekko doesn’t publish price predictions of its own.

Is Omega Healthcare Investors stock overvalued or undervalued?

On Gekko’s estimate Omega Healthcare Investors is undervalued: the Nov 13, 2026 close of $47.05 is 27.0% below Gekko Fair Value of $64.44. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.

When does Omega Healthcare Investors report earnings next?

Omega Healthcare Investors is expected to report on Feb 3, 2027 (80 days away). Analysts expect earnings of $0.51 per share on revenue of $281.4M. Omega Healthcare Investors beat the earnings estimate in 6 of its last 8 reports, moving 3.1% on average across the report.

What is Omega Healthcare Investors’s 52-week high and low?

Omega Healthcare Investors’s 52-week high is $52.39 and its 52-week low is $42.18; it closed at $47.05 on Nov 13, 2026, +7.7% over the past year.

Is Omega Healthcare Investors stock a buy right now?

Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (fair value and earnings risk), 2 as mixed (trend and gekkoindex) and 1 as a headwind (seasonality). The checklist is a description of current data, not a recommendation.

How this page works

During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →

See Omega Healthcare Investors the way Gekko members do

Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.

Join 1,475 other traders using Gekko

Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.